Comprehensive Genomic Profiling with SureSelect Cancer CGP Assay
contributed by Agilent |
With the Agilent SureSelect Cancer CGP assay, a targeted, pan-cancer panel based on next-generation sequencing (NGS) technology, you’ll have access to the most clinically relevant and up-to-date biomarker content by detecting key classes of somatic alterations. Have confidence in high-performance results optimized with error-correcting molecular barcodes, convenient enzymatic fragmentation and minimum sample input. The workflow solution is configurable to meet the needs of your lab with options to incorporate sample QC, automation, and data analysis solutions.
Log in or register to gain full unlimited access to all content on the The Pathologist site. It’s FREE!